Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EagleVision is a specialized medical device company that became a market leader in the development of ophthalmic products, specifically for the treatment of dry eye syndrome. The company is best known for its innovative punctum plugs, including the proprietary EagleVision and SuperEagle brands, which are designed to block the tear drainage system to maintain moisture on the eye surface. Founded in Memphis, Tennessee, EagleVision established a strong reputation for high-quality, tapered-shaft plugs that provide a secure fit and ease of insertion for clinicians. In 2006, the company was acquired by Bausch + Lomb, which integrated EagleVision's portfolio into its surgical and vision care divisions to enhance its dry eye management offerings. Today, the EagleVision brand remains a standard of care in optometry and ophthalmology practices worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EagleVision.